Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Braz. j. infect. dis ; Braz. j. infect. dis;21(1): 92-97, Jan.-Feb. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1039184

RESUMO

Abstract Objectives: To describe early-onset neonatal sepsis (EOS) epidemiology in a public maternity hospital in Brasilia, Brazil. Methods: We defined EOS as a positive blood culture result obtained from infants aged ≤72 hours of life plus treatment with antibiotic therapy for ≥5 days. Incidence was calculated based on the number of cases and total live births (LB). This is a descriptive study comparing the period of 2012-2013 with the period of 2014-September 2015, before and after implementation of antibiotic prophylaxis during labor for group B streptococcus (GBS) prevention, respectively. Results: Overall, 36 infants developed EOS among 21,219 LB (1.7 cases per 1000 LB) and 16 died (case fatality rate of 44%). From 2014, 305 vaginal-rectal swabs were collected from high-risk women and 74 (24%) turned out positive for GBS. After implementation of GBS prevention guidelines, no new cases of GBS were detected, and the EOS incidence was reduced from 1.9 (95% CI 1.3-2.8) to 1.3 (95% CI 0.7-2.3) cases per 1000 LB from 2012-2013 to 2014-September 2015 (p = 0.32). Conclusions: Although the reduction of EOS incidence was not significant, GBS colonization among pregnant women was high, no cases of neonatal GBS have occurred after implementation of prevention guidelines.


Assuntos
Humanos , Masculino , Feminino , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Infecções Estreptocócicas/prevenção & controle , Infecções Estreptocócicas/epidemiologia , Antibioticoprofilaxia/métodos , Sepse Neonatal/prevenção & controle , Sepse Neonatal/epidemiologia , Complicações Infecciosas na Gravidez/microbiologia , Streptococcus/efeitos dos fármacos , Esfregaço Vaginal , Brasil/epidemiologia , Incidência , Reprodutibilidade dos Testes , Fatores de Risco , Resultado do Tratamento , Escherichia coli/isolamento & purificação , Escherichia coli/efeitos dos fármacos , Infecções por Escherichia coli/prevenção & controle , Infecções por Escherichia coli/epidemiologia , Sepse Neonatal/microbiologia , Maternidades
2.
Braz J Infect Dis ; 21(1): 92-97, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27875686

RESUMO

OBJECTIVES: To describe early-onset neonatal sepsis (EOS) epidemiology in a public maternity hospital in Brasilia, Brazil. METHODS: We defined EOS as a positive blood culture result obtained from infants aged ≤72 hours of life plus treatment with antibiotic therapy for ≥5 days. Incidence was calculated based on the number of cases and total live births (LB). This is a descriptive study comparing the period of 2012-2013 with the period of 2014-September 2015, before and after implementation of antibiotic prophylaxis during labor for group B streptococcus (GBS) prevention, respectively. RESULTS: Overall, 36 infants developed EOS among 21,219 LB (1.7 cases per 1000 LB) and 16 died (case fatality rate of 44%). From 2014, 305 vaginal-rectal swabs were collected from high-risk women and 74 (24%) turned out positive for GBS. After implementation of GBS prevention guidelines, no new cases of GBS were detected, and the EOS incidence was reduced from 1.9 (95% CI 1.3-2.8) to 1.3 (95% CI 0.7-2.3) cases per 1000 LB from 2012-2013 to 2014-September 2015 (p=0.32). CONCLUSIONS: Although the reduction of EOS incidence was not significant, GBS colonization among pregnant women was high, no cases of neonatal GBS have occurred after implementation of prevention guidelines.


Assuntos
Antibioticoprofilaxia/métodos , Sepse Neonatal/epidemiologia , Sepse Neonatal/prevenção & controle , Complicações Infecciosas na Gravidez/epidemiologia , Infecções Estreptocócicas/epidemiologia , Infecções Estreptocócicas/prevenção & controle , Streptococcus/efeitos dos fármacos , Brasil/epidemiologia , Escherichia coli/efeitos dos fármacos , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/epidemiologia , Infecções por Escherichia coli/prevenção & controle , Feminino , Maternidades , Humanos , Incidência , Masculino , Sepse Neonatal/microbiologia , Gravidez , Complicações Infecciosas na Gravidez/microbiologia , Reprodutibilidade dos Testes , Fatores de Risco , Streptococcus/isolamento & purificação , Resultado do Tratamento , Esfregaço Vaginal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA